Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patients

BACKGROUND: Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer and lacks effective biomarkers. This study seeks to unravel the expression status and the prospective transcriptional mechanisms of EZH1/EZH2 in TNBC tissue samples. Moreover, another objective of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Wei, Tang, Wei, Li, Jian-Di, He, Rong-Quan, Luo, Jia-Yuan, Chen, Zu-Xuan, Zeng, Jiang-Hui, Hu, Xiao-Hua, Zhong, Jin-Cai, Li, Yang, Ma, Fu-Chao, Xie, Tian-Yi, Huang, Su-Ning, Ge, Lian-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Biochemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285492/
https://www.ncbi.nlm.nih.gov/pubmed/35846880
http://dx.doi.org/10.7717/peerj.13708

Ejemplares similares

Ejemplares similares